| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |